ERYTHROPOIETIN ATTENUATES - FULMINANT HEPATIC FAILURE INDUCED BY D - GALACTOSAMINE/LIPOPOLYSACCHARIDE IN MICE

被引：0
|
作者：
Ben Ari, Ziv [1 ,6 ]
Pappo, Orit [2 ]
Zilbermints, Veacheslav [3 ,6 ]
Avlas, Orna [4 ]
Greiff, Franklin [3 ,6 ]
Chepurko, Yelena [4 ]
Shapiro, Rivka [5 ,6 ]
Hochhauser, Edith [4 ,6 ]
机构：
[1] Rabin Med Ctr, Liver Inst, Petah Tiqwa, Israel
[2] Rabin Med Ctr, Dept Histopathol, Petah Tiqwa, Israel
[3] Rabin Med Ctr, Dept Surg A, Petah Tiqwa, Israel
[4] Felsenstein Med Res Ctr, Cardiac & Liver Res Lab, Petah Tiqwa, Israel
[5] Schneider Childrens Med Ctr Israel, Pediat Gastroenterol Inst, Petah Tiqwa, Israel
[6] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
30
引用
收藏
页码：334A / 334A
页数：1
相关论文
共 50 条
  • [31] Etoposide reduces the lethality in mice with D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure by preventing apoptosis of hepatocytes.
    Hirono, S
    Nakama, T
    Moriuchi, A
    Nagata, K
    Hori, T
    Ido, A
    Hayashi, K
    Tsubouchi, H
    HEPATOLOGY, 1999, 30 (04) : 543A - 543A
  • [32] Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure
    Feng, Bo
    Wu, Shengming
    Lv, Sa
    Liu, Feng
    Chen, Hongsong
    Yan, Xianzhong
    Li, Yu
    Dong, Fangting
    Wei, Lai
    JOURNAL OF PROTEOME RESEARCH, 2007, 6 (06) : 2161 - 2167
  • [33] Hepatoprotective Effects of Sedum sarmentosum on D-Galactosamine/Lipopolysaccharide-Induced Murine Fulminant Hepatic Failure
    Lian, Li-Hua
    Jin, Xuejun
    Wu, Yan-Ling
    Cai, Xing Fu
    Lee, Jung Joon
    Nan, Ji-Xing
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 114 (02) : 147 - 157
  • [34] Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice
    Furuya, Shinji
    Kono, Hiroshi
    Hara, Michio
    Hirayama, Kazuyoshi
    Sun, Chao
    Fujii, Hideki
    JOURNAL OF SURGICAL RESEARCH, 2015, 199 (02) : 487 - 493
  • [35] Fibronectin prevents D-galactosamine/lipopolysaccharide-induced lethal hepatic failure in mice
    Qiu, ZY
    Kwon, AH
    Tsuji, K
    Kamiyama, Y
    Okumura, T
    Hirao, Y
    SHOCK, 2006, 25 (01): : 80 - 87
  • [36] Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice
    Wang, HP
    Li, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 534 (1-3) : 194 - 201
  • [37] Dynamic Metabonomic Analysis of BALB/c Mice with Different Outcomes After D-Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure
    Feng, Bo
    Wu, Shengming
    Lv, Sa
    Fang, Junjian
    Liu, Feng
    Li, Yu
    Gao, Yan
    Yan, Xianzhong
    Dong, Fangting
    Wei, Lai
    LIVER TRANSPLANTATION, 2008, 14 (11) : 1620 - 1631
  • [38] A diterpenoid acanthoic acid from Acanthopanax koreanum protects against D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice
    Nan, Ji-Xing
    Jin, Xue-Jun
    Lian, Li-Hua
    Cai, Xing Fu
    Jiang, Ying-Zi
    Jin, Hong Ri
    Lee, Jung Joon
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (04) : 738 - 742
  • [39] Sesamin ameliorates lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice
    Ma, Li
    Gong, Xia
    Kuang, Ge
    Jiang, Rong
    Chen, Rongchun
    Wan, Jingyuan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 461 (02) : 230 - 236
  • [40] CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice
    Yan, Liping
    Hu, Xiangnan
    Wu, Qihong
    Jiang, Rong
    Zhang, Sisi
    Ling, Qiao
    Liu, Hailin
    Jiang, Xuejun
    Wan, Jingyuan
    Liu, Yingju
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 47 : 231 - 243
12345